Prospective dengue seroprevalence study in 5 to 10 year-old childre
Not Applicable
Completed
- Registration Number
- CTRI/2011/12/002243
- Lead Sponsor
- Sanofi Pasteur SA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 3230
Inclusion Criteria
Aged between 5 and 10 year-old on the day of inclusion
- Healthy child as reported by the parent or legally qualified guardian
- Being registered in selected study site
- Provision of the informed consent form signed by at least one parent or legally qualified guardian
- For children between 8 and 10 years old, provision of the assent form signed.
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of participants with dengue specific IgG antibodies in serum samplesTimepoint: Day 0
- Secondary Outcome Measures
Name Time Method Prevalence of positive samples with dengue specific serotype DENV 1, 2,3 and/or 4Timepoint: Day 0;Prevalence of positive serum samples with JEV specific IgG antibodiesTimepoint: Day 0